Insulin Management

New Options for Patients With Severe Insulin Resistance

03/04/2016

Concentrated insulin is an important tool for managing severe insulin resistance in type-2 diabetes cases. If a patient needs more than 200 units/mL each day, using the standard U-100 forms of insulin may be a burdensome therapy regimen. In this video, Dr. Cavaiola describes some of the potential benefits of two newly approved basal insulins.

In 2015, two new basal insulins (Toujeo and Tresiba) were approved for the treatment of diabetes. Toujeo is a new insulin glargine that is available in a U-300 concentration that can reduce a patient's need to inject more than once per day. Tresiba is an insulin degludec analogue that has been used in Europe since 2013 with promising results, and has just recently become available in the US. Both of these new therapies have shown the ability to reduce a patient's risk of developing hypoglycemia.

For more videos, visit our partners at The Doctor's Channel.

Related Content

Treatment
Treatment
Antivirals Currently Underutilized in Children Hospitalized Due to Influenza
04/07/2017
Michael Banks, MD, discusses a recent study that details the inconsistencies of antiviral treatment in children hospitalized with an influenza infection, despite recommendations from the Centers for Disease...
04/07/2017
Gastrointestinal Disorders
Sara Horst
Gastrointestinal Disorders
Sara Horst, MD, MPH, on Adverse Effects Associated With IBD Medications
06/18/2019
In this video, Sara Horst, MD, MPH, from Vanderbilt University Medical Center, discusses opportunistic infections in IBD, as well as how to treat patients appropriately.
06/18/2019
Surgery
Surgery
Maxillary Fungal Sinusitis
10/27/2020
Todd Schaeffer, MD, walks through a patient case where he performed surgery on a 40-year-old woman with a 1-year history of blood-tinged mucous.
10/27/2020
Gastroenterology
Gastroenterology
Great Debates and Updates in IBD (2)
08/01/2018
08/01/2018
Diagnosis Strategies
Herman Taylor
Diagnosis Strategies
Herman Taylor, Jr, MD, MPH, on the Jackson Heart Study Key Takeaways: Making the Right Diagnosis at the Right Time
10/01/2016
In this video, Herman Taylor, Jr, MD, MPH, explains how the findings from the Jackson Heart Study question the specifics of making the right diagnosis at the right time among African Americans.
10/01/2016